courtesy of Entrepreneur Magazine
The FDA will approve the Pfizer Covid-19 vaccine for 12-to 15-year-old teens as early as next week, a government official told CNN.
The official, who asked for anonymity, said that the FDA has to modify the emergency use authorization for the Pfizer vaccine. The agency’s Vaccines and Related Biological Products Advisory Committee had previously held meetings to decide whether to recommend emergency use authorization for the Moderna, Pfizer and Johnson & Johnson vaccines, but this process will not happen when extending the use of the Pfizer vaccine to teens, the FDA told CNN.
The FDA is currently reviewing Pfizer’s data for extended use, the network further added.
Pfizer said that its vaccine clinical trial on 2,260 teens of ages ranging from 12 to 15 showed a 100% efficacy, according to the company’s statement in March. Moderna is currently testing its vaccine on other age groups, including children and infants. Both are set to ask for FDA approval to cover these age groups later in 2021, according to CNN.
More than 250 million people across the U.S. have either been fully vaccinated or received one dose of the Pfizer or Moderna vaccine.
